Chemoinformaics analysis of HENEICOSANDICARBONIC-ACID
| Molecular Weight | 340.592 | nRot | 19 |
| Heavy Atom Molecular Weight | 296.24 | nRig | 1 |
| Exact Molecular Weight | 340.334 | nRing | 0 |
| Solubility: LogS | -7.119 | nHRing | 0 |
| Solubility: LogP | 9.28 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 68 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 67.6829 |
| nHD | 0 | BPOL | 46.7451 |
| QED | 0.179 |
| Synth | 1.754 |
| Natural Product Likeliness | 0.201 |
| NR-PPAR-gamma | 0.102 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -5.006 |
| MDCK | 0.00000997 |
| BBB | 0.081 |
| PPB | 0.970566 |
| VDSS | 3.294 |
| FU | 0.0126642 |
| CYP1A2-inh | 0.14 |
| CYP1A2-sub | 0.177 |
| CYP2c19-inh | 0.265 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.089 |
| CYP2c9-sub | 0.958 |
| CYP2d6-inh | 0.274 |
| CYP2d6-sub | 0.036 |
| CYP3a4-inh | 0.269 |
| CYP3a4-sub | 0.036 |
| CL | 4.635 |
| T12 | 0.118 |
| hERG | 0.401 |
| Ames | 0.006 |
| ROA | 0.016 |
| SkinSen | 0.966 |
| Carcinogencity | 0.039 |
| EI | 0.937 |
| Respiratory | 0.882 |
| NR-Aromatase | 0.051 |
| Antiviral | No |
| Prediction | 0.594267 |